Perrigo News

Perrigo's Strategic Divestiture Prompts Buy Rating From Analyst Susan Anderson

TipRanksApr 26 20:07

Perrigo Analyst Ratings

BenzingaApr 12 23:49

Perrigo's Game-Changing Opill Gains Groundbreaking CVS Coverage: A Buy Rating Endorsement

TipRanksApr 8 19:25

Piper Sandler: Maintaining the Perrigo (PRGO.US) rating, adjusted from an increase to an increase rating, and the target price was adjusted from $35.00 to $39.00.

Zhitong FinanceApr 8 19:20

Perrigo Analyst Ratings

BenzingaApr 8 19:15

Piper Sandler Remains a Buy on Perrigo Company (PRGO)

TipRanksApr 5 18:47

JP Morgan Maintains Overweight on Perrigo, Lowers Price Target to $41

BenzingaFeb 28 22:57

Perrigo Analyst Ratings

BenzingaFeb 28 22:56

Piper Sandler Remains a Buy on Perrigo Company (PRGO)

TipRanksJan 12 20:37

Piper Sandler Issues a Buy Rating on Perrigo Company (PRGO)

TipRanksJan 3 20:51

Piper Sandler Initiates Coverage On Perrigo With Overweight Rating, Announces Price Target of $37

BenzingaNov 17, 2023 18:07

Perrigo Analyst Ratings

BenzingaNov 17, 2023 18:05

Perrigo Company's Stock: A Buy Rating Amid Margin Improvements and Potential Upside From Opill Launch

TipRanksNov 8, 2023 20:43

Perrigo Analyst Ratings

BenzingaAug 10, 2023 00:36

Canaccord Genuity Initiates Coverage On Perrigo With Buy Rating, Announces Price Target of $49

BenzingaMar 7, 2023 21:45

Raymond James Adjusts Perrigo Price Target to $43 From $42, Maintains Outperform Rating

MT NewswiresMar 6, 2023 21:42

Raymond James Reaffirms Their Buy Rating on Perrigo Company (PRGO)

TipRanksMar 5, 2023 20:51

Analysts Offer Insights on Healthcare Companies: Perrigo Company (PRGO), FibroGen (FGEN) and Disc Medicine (IRON)

TipRanksFeb 28, 2023 19:46

Raymond James Adjusts Price Target on Perrigo Company to $42 From $48, Maintains Outperform Rating

MT NewswiresNov 9, 2022 23:41

Raymond James Maintains Outperform on Perrigo, Lowers Price Target to $42

Benzinga Real-time NewsNov 9, 2022 20:41